Epigenetic silencing of miR-137 induces resistance to bicalutamide by targeting TRIM24 in prostate cancer cells.

Guan, Yonghui; Guan, Xiaoyue; An, Hengqing; Baihetiya, Azhati; Wang, Wenguang; Shao, Weimin; Yang, Haiou; Wang, Yujie

Guan, Yonghui; Guan, Xiaoyue; An, Hengqing; Baihetiya, Azhati; Wang, Wenguang; Shao, Weimin; Yang, Haiou; Wang, Yujie.

Afiliação

Guan Y; Urological Center, NO1 Hospital Affiliated to Xinjiang Medical University Urumqi 830054, Xinjiang, China.
Guan X; Department of Periodontitit, School of Dentistry of Xinjiang Medical University Urumqi 830054, Xinjiang, China.
An H; Urological Center, NO1 Hospital Affiliated to Xinjiang Medical University Urumqi 830054, Xinjiang, China.
Baihetiya A; Urological Center, NO1 Hospital Affiliated to Xinjiang Medical University Urumqi 830054, Xinjiang, China.
Wang W; Urological Center, NO1 Hospital Affiliated to Xinjiang Medical University Urumqi 830054, Xinjiang, China.
Shao W; Urological Center, NO1 Hospital Affiliated to Xinjiang Medical University Urumqi 830054, Xinjiang, China.
Yang H; School of Clinical Medicine of Xinjiang Medical University Urumqi 830054, Xinjiang, China.
Wang Y; Urological Center, NO1 Hospital Affiliated to Xinjiang Medical University Urumqi 830054, Xinjiang, China.

Am J Transl Res ; 11(5): 3226-3237, 2019.

Article em En | MEDLINE | ID: mdl-31217891

Palavras-chave

TRIM24; bicalutamide resistance; miR-137; proliferation; prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Am J Transl Res Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google